Πέμπτη 3 Αυγούστου 2017

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

Future Oncol. 2017 Aug 02;:

Authors: Nocera NF, Lee MC, Czerniecki BJ

PMID: 28766964 [PubMed - as supplied by publisher]



from #PM All via ola Kala on Inoreader http://ift.tt/2vs2XAT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου